Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1985 Aug;55(2):417-23.
doi: 10.1128/JVI.55.2.417-423.1985.

Human T-cell lymphotropic virus type III: immunologic characterization and primary structure analysis of the major internal protein, p24

J M Casey, Y Kim, P R Andersen, K F Watson, J L Fox, S G Devare
Comparative Study

Human T-cell lymphotropic virus type III: immunologic characterization and primary structure analysis of the major internal protein, p24

J M Casey et al. J Virol. 1985 Aug.

Abstract

The major internal structural protein of human T-cell lymphotropic virus type III (HTLV-III), a virus etiologically implicated in acquired immunodeficiency syndrome (AIDS), was purified to homogeneity. This 24,000-molecular-weight protein (p24) was shown to lack immunologic cross-reacting antigenic determinants shared by other known retroviruses, including HTLV-I and HTLV-II, with the exception of equine infectious anemia virus (EIAV). A broadly reactive competition immunoassay was developed in which antiserum to EIAV was used to precipitate 125I-labeled HTLV-III p24. Although the major structural proteins of HTLV-III and EIAV competed in this assay, other type B, C, and D retroviral proteins lacked detectable reactivity. Thus, HTLV-III is more related to EIAV than to any other retroviruses. That the HTLV-III isolate is very distinct from HTLV-I and HTLV-II was further confirmed by the amino acid compositions of the major internal antigens of all three isolates. Moreover, comparison of the amino-terminal amino acid sequence of HTLV-III p24 with analogous sequences for HTLV-I and HTLV-II p24 showed that these proteins do not share significant sequence homology. In an attempt to evaluate immune response in individuals exposed to HTLV-III, sera from AIDS and lymphadenopathy syndrome patients as well as from clinically normal blood donor controls were tested for antibodies to HTLV-III p24. The results showed that sera from 93% of lymphadenopathy syndrome patients and 73% of AIDS patients exhibited high-titered antibodies to HTLV-III p24. In contrast, none of the normal control sera showed detectable reactivity to HTLV-III p24.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Virol. 1979 Feb;29(2):523-8 - PubMed
    1. J Virol. 1978 Jun;26(3):577-83 - PubMed
    1. Proc Natl Acad Sci U S A. 1979 Jun;76(6):2996-3000 - PubMed
    1. Proc Natl Acad Sci U S A. 1980 Jan;77(1):72-6 - PubMed
    1. J Virol. 1980 Jan;33(1):522-30 - PubMed

Publication types

MeSH terms

LinkOut - more resources